Results 41 to 50 of about 31,899 (217)

Altered microbiome of serum exosomes in patients with acute and chronic cholecystitis

open access: yesBMC Microbiology
Background This study aimed to investigate the differences in the microbiota composition of serum exosomes from patients with acute and chronic cholecystitis.
Qing Zhu   +8 more
doaj   +1 more source

Performance of Diagnostic Guidelines in the Evaluation of Choledocholithiasis in Patients With Acute Biliary Presentation: A Systematic Review and Meta‐Analysis

open access: yesWorld Journal of Surgery, EarlyView.
Optimal management of acute biliary disease should include an assessment for possible choledocholithiasis (CBDS). Various diagnostic guidelines have been developed by expert bodies for this purpose, but uncertainties remain about their performance in wider practice.
Henry C. K. Kwok   +4 more
wiley   +1 more source

A Retrospective Study on Use of Neutrophil‐Lymphocyte Ratio as a Prognostic Measurement to Assess Acute Diverticulitis

open access: yesANZ Journal of Surgery, EarlyView.
Graphical abstract representation of Neutrophil‐lymphocyte ratio use as a prognostic marker in acute diverticulitis. ABSTRACT Background Acute diverticulitis (AD) is a common surgical condition and the Neutrophil‐lymphocyte ratio (NLR) is an emerging biomarker ratio used to guide its management.
Yam Ting Ho   +9 more
wiley   +1 more source

A Case Report of Acute Acalculous Cholecystitis and Acute Hemorrhagic Cystitis due to Salmonella Typhi

open access: yesCase Reports in Medicine, 2014
Acute acalculous cholecystitis and acute hemorrhagic cystitis due to Salmonella Typhi are a rare condition. A 24-year-old female patient was admitted to our clinic with abdominal pain, nausea, fever, headache, urinary burning, and bloody urine.
Hatice Beyazal Polat   +2 more
doaj   +1 more source

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Globally, cardiovascular diseases (CVDs) account for around one‐third of all deaths. Clinical trial evidence suggests that treatment of people with obesity or type 2 diabetes (T2D) and CVD with glucagon‐like peptide‐1 (GLP‐1) receptor agonists reduces the risk of major adverse cardiovascular events, heart failure outcomes and all‐cause ...
Naveed Sattar   +5 more
wiley   +1 more source

Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Recent advancements in haemophilia treatment have introduced a range of innovative therapies, including activated FVIII mimetics, ultra‐extended half‐life recombinant FVIII, rebalancing agents and gene therapy. These developments have transformed treatment options and expanded prophylaxis strategies.
Yesim Dargaud   +5 more
wiley   +1 more source

Synchronous acute appendicitis and acute cholecystitis, is it a myth or reality? A literature review

open access: yesOpen Access Emergency Medicine, 2019
Fatemah Buhamed,1 Maged Edward,2 Abdullah Shuaib21Department of General Surgery, Mubarak Al-kabeer Hospital, Kuwait, Kuwait; 2Department of General Surgery, Mubarak Al-kabeer Hospital, Kuwait, KuwaitAbstract: Acute appendicitis and acute cholecystitis ...
Buhamed F, Edward M, Shuaib A
doaj  

Comparison of the Role of High Neutrophil to Lymphocyte Ratio with Leukocytosis in Diagnosing Acute Cholecystitis

open access: yesPakistan Armed Forces Medical Journal, 2023
Objective: To compare the diagnostic accuracy of high neutrophil-to-lymphocyte ratio levels versus leukocytosis in detecting acute cholecystitis. Study Design: Cross-sectional validation study.
Muhammad Umair Khalid   +5 more
doaj   +1 more source

Gaucher disease, state of the art and perspectives

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source

Acute cholecystitis

open access: yesActa chirurgica Iugoslavica, 2003
Only 20 - 30% of patients with gallstones have symptoms and the probability of a patient with silent gallstones developing biliary-related pain is 1- 2% while the risk of developing a serious complication (e.g. empyema, perforation, peritonitis etc.) is less than 0.1% per year.
openaire   +3 more sources

Home - About - Disclaimer - Privacy